Constructing a Novel Prognostic Signature Based on TGF-β Signaling for Personalized Treatment in Pancreatic Adenocarcinoma

Figure 4

Mutation features of high-risk and low-risk groups. (a and b) Comparison of TMB (a) and the number of mutated genes (b) in high-risk and low-risk groups. Student t test was performed. (c) Mutation patterns of significantly mutated genes in high-risk and low-risk groups. TMB, tumor mutation burden. Ns, no significance, .

(a)

(b)

(c)